Coagadex® (coagulation Factor X [human]) – Expanded indication
April 14, 2023 - The FDA approved Bio Products Laboratory’s Coagadex (coagulation Factor X [human]), in adults and children with hereditary Factor X deficiency for perioperative management of bleeding in patients with mild, moderate, and severe hereditary Factor X deficiency.
Top